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MARK, a Novel Family of Protein Kinases
That Phosphorylate Microtubule-Associated
Proteins and Trigger Microtubule Disruption
Gerard Drewes, Andreas Ebneth, Ute Preuss, tau at a single residue, Ser-262, dramatically reduced
MT binding (Biernat et al., 1993). This residue is locatedEva-Maria Mandelkow, and Eckhard Mandelkow
Max-Planck-Unit for Structural Molecular Biology in the KXGS sequence within the first of three or four
imperfectly repeated motifs that are part of the MT-Notkestrasse 85, GebaÈ ude 25B
D-22603 Hamburg binding domain. The degree of phosphorylation at KXGS
motifs is normally low (Seubert et al., 1995), consistentGermany
with a tight association of tau with MTs. It has been
shown, however, that phosphorylation of Ser-262 is ele-
vated in tau protein isolated from the neurofibrillary tan-Summary
gles of Alzheimer's disease (Hasegawa et al., 1992), con-
comitant with a loss of MT binding and aggregation intoMARK phosphorylates the microtubule-associated pro-
paired helical filaments (reviewed in Mandelkow et al.,teins tau, MAP2, and MAP4 on their microtubule-bind-
1995).ing domain, causing their dissociation from micro-
We partially purified a kinase activity with an apparenttubules and increased microtubule dynamics. We
molecular mass of 110 kDa (Drewes et al., 1995) thatdescribe themolecular cloning, distribution, activation
phosphorylates the neuronal MAPs tau and MAP2 andmechanism, and overexpression of two MARK pro-
the ubiquitous MAP4 on their homologous KXGS motifsteins from rat that arise from distinct genes. They en-
(Illenberger et al., 1996). The kinase caused rapid de-code Ser/Thr kinases of 88 and 81 kDa, respectively,
tachment of all three MAPs from MTs, resulting in highand show similarity to the yeast kin11 and C. elegans
dynamic instability, and was therefore termed MARKpar-1 genes that are involved in the establishment of
(MAP/microtubule affinity-regulating kinase). Here wecell polarity. Expression ofboth isoforms is ubiquitous,
report the cloning of two cDNAs for MARK encodingand homologous genes are present in humans. Cata-
protein Ser/Thr kinases that are ubiquitously expressedlytic activity depends on phosphorylation of two resi-
and show a characteristic domain structure with rela-dues in subdomain VIII. Overexpression of MARK in
tionship togenes from yeast and C. elegans. The expres-cells leads to hyperphosphorylation of MAPs on KXGS
sion of both isoforms in Chinese hamster ovary (CHO)motifs and to disruption of the microtubule array, re-
cells causes the disruption and disappearance of MTs.sulting in morphological changes and cell death.
Introduction Results
Cloning of the Protein Kinase MARKThe microtubule array plays a central role in a number
of cellular processes, such as the regulation of cell Reveals Two Genes
Recently, we have purified a protein kinase activity thatshape and cell polarity during differentiation, chromo-
some partitioning at mitosis, and intracellular transport was remarkably efficient in blocking the interactions be-
tween MTs and MAPs. We designed a substrate peptide(reviewed by Drubin and Nelson, 1996; Hyman and
Karsenti, 1996). During these processes, microtubules that stems from the main target site on human tau pro-
tein around Ser-262. The peptide is specifically phos-(MTs) undergo rearrangements involving rapid transi-
tions between stable and dynamic states (Sammak and phorylated by MARK but not by protein kinase A (PKA),
which also has a low affinity for the corresponding siteBorisy, 1988). This phenomenon, termed dynamic insta-
bility, is a property of the polymer itself (Mitchison and in tau (Drewes et al., 1995). Using the peptide to screen
for activity of column fractions, 20 mg of pure enzymeKirschner, 1984) but is modulated by cellular factors
(Belmont and Mitchison, 1996; Walczak et al., 1996). was purified. The presence of detergent (0.03% Brij-35)
during extraction was essential, suggesting an associa-These include the microtubule-associated proteins
(MAPs) and filamentous proteins, which stabilize MTs tion with membranous components. In total, the proce-
dure resulted in a 10,000-fold purification (Table 1).in vitro (Pryer et al., 1992) and in transfected cells (Ume-
yama et al., 1993). Phosphorylation of MAPs interferes These data suggest that the enzyme is a low abundance
protein in brain.with their MT-stabilizing capacity (Shiina et al., 1992;
Trinczek et al., 1995). MAPs isolated from tissue or cells Endoprotease Lys-C digestion and peptide sequenc-
ing yielded several sequences, two of which were usedshow a varying degree of phosphorylation (Vallee, 1980;
Watanabe et al., 1993). In mitotic cells, MAPs exhibit a to design degenerate primers for RT±PCR (Table 2). A
288 bp fragment was amplified from both rat and humanseveral-fold higher degree of phosphorylation (Vandre et
al., 1991; Preuss et al., 1995), and MT dynamics increase brain mRNA, which contained an open reading frame
that corresponded to theC-terminal portionof peptide 5,about 20-fold (Saxton et al., 1984). In neurons, MAPs
modulate MT organization during morphogenesis and and the lysine residue juxtaposing the 39 oligonucleotide
was consistent with cleavage (data not shown). Screen-process outgrowth (Caceres and Kosik, 1990; Dinsmore
and Solomon, 1991), but even in the axons of mature ing of a rat brain library with the PCR fragment yielded
two types of cDNA derived from distinct genes. Oneneurons the dynamic nature of MAP±MT interactions
has been shown (Mercken et al., 1995). group contained clones of identical sequence with in-
complete but overlapping open reading frames. OneWe found that phosphorylation of the neuronal MAP
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Table 1. Purification of MARK from 2 kg of Porcine Brain
Total Protein Total Activity Specific Activity Recovery
Stage (mg) (nmol/min) (nmol/min/mg) (%) Purification (fold)
Extract 14800 2214 0.15 100 1
Phosphocell. 1500 2212 1.50 100 10
Q-Seph. 216 1512 7.00 68 47
Mono S 55 1072 19.50 48 130
Mono Q 24 655 27.30 29 182
G200 6 414 69.20 19 461
ATP±Seph. 0.05 82 1500 4 10000
clone contained the termination codon, and another 1990), and the par-1 gene of C. elegans (70%; Guo and
Kemphues, 1995). Moreover, there is a high degree ofcontained a putative translational start site (Kozak,
1987). This region of 200 bp showed an 80% G1C con- homology with two mammalian sequences: EMK, a pu-
tative kinase on mouse chromosome 19 (Inglis et al.,tent, but no upstream stop codons were found. From
these two clones, an open reading frame of 793 amino 1993) that is highly related to MARK2 (97% identity), and
human p78 (GenBank no. M80359; unpublished data),acids encoding a protein of 88 kDa was derived and
termed MARK1. All of the sequenced peptides aligned which shows 75% homology to MARK1 and 67% to
MARK2. In both cases, the encoded proteins have notwith the predicted sequence, suggesting that it is the
predominant isoform in the isolated enzyme (Figure 1A). been characterized. Evidently, the human MARK1/
MARK2 homologs and p78 are distinct members of aSome variations in sequence are noted, mostly in pep-
tides from the regions outside the catalytic domain, new protein kinase family.
which are probably less well conserved among species.
The second group of cDNAs contained one complete Tissue Distribution
and several incomplete clones showing a 72% overall
Northern blots were hybridized with oligonucleotides
identity with MARK1. The predicted protein, termed
complementary to sequence regions unique for MARK1
MARK2, consists of 722 residues with a molecular mass
or MARK2. MARK1-specific probes labeled a 4.6 kb
of 81 kDa and aligns with 7 of the purified peptides. The
mRNA predominantly in rat brain and spleen but also in
remaining peptides are unique for MARK1, while none
kidney and skeletal muscle. In other tissues, expression
is unique for MARK2. Making use of the rat sequences,
levels were low (Figure 2). The blot was reprobed with
we have cloned human MARK genes by PCR, yielding
MARK2-specific oligonucleotides, which detected a 4.5
sequences with high homology (around 90%) to either
kb band in all tissues. The hybridization pattern was
rat MARK1 orMARK2, even inuntranslated regions (data
similar to MARK1. In adult and fetal human tissues, the
not shown).
rat oligonucleotides detect distinct mRNAs for MARK1
and MARK2, 4.1 and 4.7 kb in size, respectively (Figure
Homologies, Domains, and Structural Predictions
2, right panels). The low intensity of the hybridization
We subdivide the MARK sequences into the following
signal is presumably due to mismatches between the
domains: (i) a divergent N-terminal header sequence; (ii)
oligonucleotides and the human mRNAs. The tissue dis-
a catalytic domain of 30 kDa containing the common
tribution is comparable to that observed in rat tissues.
protein kinase motifs; (iii) a ubiquitin-associated (UBA)
Fetal tissues showed higher expression levels, espe-
domain (Hofmann and Bucher, 1996); (iv) an extended
cially in the kidney. In 7-day mice embryos, we observed
spacer region characterized by its highly basic and pro-
no expression of MARK1 and low levels of MARK2, but
nounced hydrophilic character; and (v) a 110-residue
expression of both isoforms became prominent after 11
C-terminal tail that is basic but more hydrophobic (Fig-
days, concomitant with tau expression (data not shown).
ure 1B). Homology between MARK1 and MARK2 is high
in the catalytic domain (95%), the UBA domain (85%),
and the C-terminal domain (80%) but drops to 50% in Specificity and Regulation of MARK Activity
MARK purified from brain migrates on SDS gels as athe spacer region. There is little secondary structure
predicted in the spacer region (PHDsec; Rost and fuzzy band with an apparent molecular mass of around
110 kDa (Figure 3A, lane 1), whereas in vitro-translatedSander, 1993), but the C-terminus contains two putative
amphipathic helices (Segrest et al., 1990). MARK1 and MARK2 migrated at 100 and 90 kDa, respec-
tively (Figure 3A, lanes 4 and 6), which is slightly higherPhylogenetic analysis of the catalytic domain places
MARK in the Snf1/AMPK subfamily of the Ca21/calmod- than predicted, a behavior similar to that reported for
theproducts of theyeast genes KIN1 and KIN2 (Donovanulin-dependent kinase II (CaMK) group (Hanks and
Hunter, 1995) (Figure 1C). Note that although the motif et al., 1994). Incubationof brain MARK with phosphatase
2A (PP2A) resulted in a downward shift, both with brainphosphorylated by MARK, i.e., KXGS, is similar to the
consensus motifs of PKA, PKC, and CaMK (Kemp and MARK (lane 2) and with proteins translated in vitro (Fig-
ure 3A, lanes 5 and 7). In the presence of the phospha-Pearson, 1990), these kinases do not phosphorylate the
repeat domain of tau to a comparable extent (Steiner tase inhibitor microcystin-LR, higher mobility bands
were not observed (Figure 3A, lane 3). Hence, the forma-et al., 1990). Pronounced homologies are found with the
S. cerevisiae genes KIN1 and KIN2 (50%; Levin et al., tion of the fast-migrating band (at 90 kDa) could be due
to higher susceptibility of the dephosphorylated protein1987), the S. pombe gene kin1 (50%; Levin and Bishop,
MARK Kinases Trigger Microtubule Disruption
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Figure 1. Mammalian Kinases MARK1 and MARK2 and Their Relatives from Nematode and Yeast
(A) Alignment of the predicted amino acid sequences of MARK1 and MARK2 with PAR-1 (C. elegans; Guo and Kemphues 1995) and kin11
(S. pombe; Levin and Bishop, 1990) using CLUSTALW (Thompson et al., 1994). Identical residues are shaded in black, similar residues in
grey. The activating phosphorylation sites in subdomain VIII are indicated by dots. Dashed lines above the sequence indicate porcine MARK
peptides (Table 2). The catalytic domain is subdivided into subdomains I±XI. Within the tail domain, two predicted amphipathic helices are
indicated by ªa,º N713±L723 and I777±L793.
(B) Diagram of the proposed domain structure of MARK kinases (see text).
(C) Dendrogram of an alignment of the kinases of the SNF1/AMPK subfamily.
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Table 2. Peptides Obtained from a Lys-C Digest of Porcine MARK
Peptide Fraction Residue No. MARK Isoform Peptide Sequence
1 71 34±48 1 (K) XSSRQNIPRCRNNII
...............S.T
2 88 113±121 1, 2 (K) ILNHPNIVK
3 140 163±176 1, 2 (K) FRQIVSAVQYCHQK
4 47 185±197 1, 2 (K) AENLLLDADMNIK
5 87 213±231 1, 2 (K) LDTFCGSPPYAAPELFQGK
6 130 274±286 1, 2 (K) YRIPFYMSTDCENLLK
7 120 291±298 1 (K) LFVLNPIK
....L......
8 33 308±328 1 (K) DRWMNVGHEEEELKPYAEPEP
...................S...L
9 140 335±345 1 (K) RIDIMVTMGFL
.............A
10 93 409±418 1 (K) VQRSISANQK
11 49 440±448 (1, 2) (K) PQAXNADSE
R...NSVE..
12 9 451±460 (1) (K) EEWDRDVARK
.......K.T..R
13 41 786±793 1, 2 (K) IANELK
The sequences deduced from the rat cDNA for MARK are listed below the peptides where they differ (see Figure 1). Phosphorylated residues
in peptide 5 are marked. Peptides 5 and 8 were used for primer construction.
to proteolysis. MARK from brain was also phosphory- not with PTP1B. The presence of ATP during the prein-
lated on tyrosine, as detected by immunoblotting (Figure cubation led to a small increase in activity, which could
3A, lanes 8±10). be due to autophosphorylation or a copurifying activat-
Dephosphorylation of MARK also affects catalytic ac- ing factor. The in vitro-translated proteins were also
tivity. We assayed the phosphorylation of peptide TR1 sensitive to PP2A treatment (Figure 3A, lanes 5 and
after various incubation times (Figure 3B), revealing that 7). In a number of known protein kinases, a region in
complete inactivation could be achieved with PP2A but subdomain VIII isa target for activating phosphorylation,
particularly at a conserved Thr residue (Johnson et al.,
1996). We sequenced the corresponding peptide from
brain MARK (Table 2, peptide 5). Edman degradation
revealed the absence of phenylthiohydantoine (PTH)
peaks for Thr and Ser in cycles 3 and 7, instead of which
PTH-a-aminodehydrobutyric acid and PTH-dehydro-
alanine, the products of phospho-Thr and phospho-Ser,
appeared (data not shown). The phospho-Thr aligns with
the threonines that are essential for activity in a number
of protein kinases (Figure 3C). Translation of wild-type
and mutant MARKs in reticulocyte lysates showed that
activity was lost when each of these residues alone, or
both together, were mutated into Ala, and the electro-
phoretic mobility of the proteins increased. Mutation of
the essential Lys residue in subdomain II also resulted
in an inactive enzyme that displayed increased mobility,
suggesting that the recombinant kinases are activated
via autophosphorylation (Figure 3D).
The substrate specificity of the recombinant kinases
Figure 2. MARK Expression Is Pronounced in Brain, Spleen, Kidney was investigated by phosphopeptide mapping (Figure
and Muscle 3E). Tryptic maps of tau phosphorylated with in vitro-
Northern blot analysis of 2 mg of mRNA from rat and human tissues. translated MARK1 or MARK2 were similar to a map
Size markers in kilobases are indicated. The upper blots show hy-
obtained from tau phosphorylated with the kinase puri-bridization with MARK1-specific oligonucleotides. Expression is
fied from brain. The pattern shows the typical phosphor-pronounced in brain and spleen, but also in skeletal muscle and
kidney. The 6.5 kb band in muscle possibly represents an unrelated ylation of KXGS motifs, containing Ser-262, -293, -324,
mRNA, since it does not hybridize to a cDNA probe for MARK (data and -356. This result suggests that there is no obvious
not shown). The lowerblots show hybridization with MARK2-specific difference in specificity between MARK1 and MARK2.
probes. Expression is prominent in brain, spleen, muscle, and kid-
The fact that the specificity of the recombinant enzymesney. In humans, MARK-related mRNAs are prominent in heart and
was comparable to that of the enzyme purified frommuscle. Relatively high levels of a MARK2-related mRNA are found
in fetal tissues. tissue confirms identity or close relationship of the
cloned kinases with the brain enzyme.
MARK Kinases Trigger Microtubule Disruption
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Figure 3. MARK Is Phosphorylated on Ser, Thr, and Tyr Residues, and its Activity Depends on Phosphorylation of Thr-215 and Ser-219
(A) Silver-stained gel showing porcine MARK (lane 1), the same sample after a 20 min incubation with 10 mg/ml PP2A (lane 2), and a control
where PP2A was inhibited by microcystin-LR (lane 3). Note the mobility shift concomitant with dephosphorylation. The additional higher
mobility bands at 90 kDa are reproducibly formed and could result from an increased proteolytic susceptibility of the dephosphorylated
protein. Lanes 4±7 show rat MARK1 and MARK2 translated in reticulocyte lysates, detected by blotting with MARK C-terminal antiserum.
Lane 4, MARK1; lane 5, MARK1 dephosphorylated; lane 6, MARK2; lane 7, MARK2 dephosphorylated. Lanes 8±10 show a phosphotyrosine
immunoblot. Brain MARK is tyrosine phosphorylated (lane 8), which is sensitive to PTP1B treatment (lane 9) but not to PP2A (lane 10).
(B) Brain MARK activity as dependent on autophosphorylation or dephosphorylation. Purified MARK was incubated with either 100 mM ATP
(closed circles), PTP1B (10 mg/ml, open squares), or PP2A (10 mg/ml, open circles). After the indicated time, aliquots were tested for their
ability to phosphorylate peptide TR1. Tyr dephosphorylation does not cause a significant decrease in activity, whereas the dephosphorylation
of Ser/Thr residues results in complete inactivation.
(C) Alignment of the sequence of a phosphopeptide isolated from porcine brain MARK (Table 2) with the corresponding sequences from
several kinases. The phosphorylated Thr-215 in MARK corresponds to the regulatory Thr residue in PKA, CDKs, ERKs, and MEKs.
(D) Point mutations in subdomain VIII affect MARK activity. The activating phosphorylation sites and an essential Lys residue were mutated
in MARK1 and MARK2 plasmids as indicated. From these, synthetic RNAs were translated in reticulocyte lysate, and the products immunopre-
cipitated with anti-HA and anti-C-terminal antibodies. Ablot of the samples with the C-terminal antibody is shown. The dephosphorylated sample
(lane 2) and the mutants (lanes 4±7 and 9±12) display increased electrophoretic mobility. Catalytic activity was assayed by autoradiography after
incubation with [g-32P]ATP and tau. Only the wild-type enzymes phosphorylate tau efficiently.
(E) Specificity of recombinant MARK. Tryptic digests of the tau samples phosphorylated with MARK1 (lane 8 in [D]) or MARK2 (lane 3 in [D])
were mapped by thin-layer electrophoresis (horizontal) followed by ascending chromatography (vertical). The main spots correspond to the
four KXGS motifs in the tau repeats (Drewes et al., 1995). For comparison, a map of tau phosphorylated with porcine brain MARK is shown.
Overexpression of MARK in CHO Cells striking (Figure 4B). Often, the MTs had almost entirely
disappeared. The effect of MARK1 was similar but lessBy phosphorylating MAPs, MARK catalyzes their de-
tachment from MTs, which results in a decrease in MT severe (Figure 4D). Most transfected cells still showed
the typical MT staining pattern, although the networkstability in vitro (Drewes et al., 1995). We therefore inves-
tigated if the kinases would exert a similar effect on the appeared less dense compared with the surrounding
nontransfected cells. The transfected cells marked withMT array in vivo. CHO cells were transiently transfected
with epitope-tagged MARK1 or MARK2 and analyzed arrowheads show the early stage of destruction of the
MT network. It is interesting to note that we did notby immunofluorescence. A large number of the MARK2-
overexpressingcells (Figure 4A) were clearly smaller and observe a destruction of the microfilament network in
triple immunofluorescence experiments where labeledmore rounded than nontransfected or mock-transfected
cells. Besides the small and rounded cells that were phalloidin was used to stain actin (data not shown).
To check if these effects were caused by the phos-obviously no longer viable, we also observed cells that
stained positively for the transfected protein but still phorylating activity of the transiently expressed MARK
or by other effects of the overexpression, cells wereappeared relatively normal in shape and size. In many
of these cells, the disruption of the MT network was transfected with catalytically inactive mutants. These
Cell
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Figure 4. Overexpression of MARK in CHO
Cells Causes Breakdown of the Microtubule
Array
Double immunofluorescence microscopy of
HA-tagged MARKs transfected into CHO
cells. After 24 hr, cells were fixed with metha-
nol and stained with anti-HA (left panels) and
anti-tubulin (YL1/2) antibodies (right panels).
Scale bar 5 5 mm.
(A) MARK2-transfected cells tend to be
smaller and more rounded in shape, and
eventually die.
(B) MARK2-transfected cells showing a dra-
matic loss of MTs.
(C) Transfection with catalytically inactive
MARK2T208A/S212A. In contrast to wild-type
MARK2, no effect on the MT network is
visible.
(D) Cells transfected with MARK1. MT de-
struction is also observed (arrowheads) but
is less pronounced compared to MARK2
overexpression. The staining pattern of the
transfected MARK1 is clearly distinct from
that of MARK2.
(E) Transfection with inactive MARK1T215A/S219A.
No effect on the MT network is visible.
cells remained viable, had a normal appearance, and a punctate distribution throughout the cytoplasm, as if it
was located to vesicles, whereas the staining of MARK1had an intact MT network (Figures 4C and 4E), indicating
that the loss of MTs was a consequence of phosphory- suggests its localization to an intracellular network
(compare Figure 4B and 4C with 4D and 4E). Note thatlation.
The staining of the transfected cells revealed a distinct the inactive mutants show the same staining pattern as
the active enzymes.cytosolic localization for each isoform. MARK2 showed
MARK Kinases Trigger Microtubule Disruption
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The effects of MARK overexpression manifest already
8 hr after transfection. The proportion of abnormal cells
increases to about 60% of MARK2-positive cells and
40% of MARK1-positive cells after 20 hr (Figure 5A).
This can be blocked by the MT-stabilizing drug taxotere
(Figure 5B) or by overexpression of MAP2c. Cotransfec-
tion of MAP2cS319A/S350A, a mutant that binds to MTs irre-
spective of MARK phosphorylation (Illenberger et al.,
1996), was more effective than wild-type MAP2c incoun-
teracting the effects of MARK (Figure 5C). This suggests
that the destruction of the MT cytoskeleton directly cor-
relates with the phosphorylation of KXGS motifs.
Since the deleterious effects of the overexpres-
sion precluded the recovery of consecutively MARK-
expressing cells, we established stable cell lines of
MARK2 under control of a doxycyclin-inducible pro-
moter (Gossen et al., 1995). Up to 90% of these cells
express MARK, with 5- to 10-fold lower expression lev-
els than in the transient tranfectants, as judged by immu-
nofluorescence. Accordingly, the phenotypic effects are
less severe, but still easily discernible, and are counter-
acted by coexpression of tau (Figure 6, upper left panel)
or MAP2c, similar to the experiment of Figure 5. Endoge-
nous MAPs in CHO cells are as yet uncharacterized,
and their expression level is low (Barlow et al., 1994);
however, the inducible MARK-expressing cells could be
transiently cotransfected with tau or MAP2c (Figure 6,
left panels). For the detection of site-specific MAP phos-
phorylation, we used a phosphorylation-dependent anti-
body that was raised against a phospho-KXGS peptide
from the first repeat of tau (12E8) (Seubert et al., 1995).
After MARK expression had been induced, the tau-
Figure 5. The Phenotypical Effects of MARK Can Be Blocked bytransfected cells brightly stained with the 12E8 antibody
Taxotere or Coexpression of MAP2c(Figure 6, right panels), whereas the staining of endoge-
(A) Time course of the appearance of morphologically abnormalnous CHO proteins was not observed. In immunoblots
cells after transfection with MARK2 (open circles), MARK1 (squares)of CHO cell extracts, however, a heat-stable 200 kDa
and the inactive MARK2T208A/S212A mutant (closed circles). Trianglesband became 12E8 immunoreactive upon induction of
show mock-tranfected cells for control. Cells were analyzed by im-
MARK2 expression (data not shown). munofluorescence with anti-HA and anti-tubulin antibodies and re-
garded as ªmorphologically abnormalº if they were less than 30% of
the average size of untransfected cells, with no distinct MT network
Discussion visible.
(B) Blocking of MARK2 effects by the microtubule-stabilizing drug
taxotere. Cells were counted 18 hr after transfection, as in (A), inThis study was originally prompted by several observa-
parallel experiments with and without 10 mM taxotere.tions relating the phosphorylation of tau protein to Alz-
(C) Partial blocking of MARK2 effects by cotransfection with MAP2c.
heimer's disease. Aggregated tau is the main constit- MAP2cS319A/S350A, a mutant in which the two main MARK phosphoryla-
uent of the paired helical filaments in the neurofibrillary tion sites have been eliminated, was more effective in counteracting
tangles. The accumulation of these deposits in brain is MARK2 effects than wild-type MAP2c. About 400 cells werecounted
in each experiment, and mean values of three independent experi-related to the progression of the dementia (reviewed in
ments 6 SD are shown.Mandelkow et al., 1995). Tau is an MT-associated pro-
tein that is thought to stabilize axonal MTs (Binder et
al., 1985). However, tau extracted from tangle prepara-
tions no longer binds to MTs, and this in turn is presum- sites with similar effects on MT dynamics (Illenberger
et al., 1996).ably related to MT breakdown, interruption of axonal
transport, and aggregation into PHFs. Tau isolated from Two related cDNAs were cloned from a rat brain li-
brary, MARK1 (793 residues) and MARK2 (722 residues)tangles shows characteristically high levels of phos-
phorylation, particularly at Ser/Thr-Pro motifs, but also (Figure 1). Their sequences may be broadly subdivided
into five domains: (i) an N-terminal header, (ii) a catalyticat othersites, a prominent one being Ser-262 (Hasegawa
et al., 1992). Phosphorylation of this residue turned out domain, (iii) a UBA domain, (iv) a spacer region, and
(v) a C-terminal tail. The header shows little predictedto impair strongly tau±MT interactions in vitro (Biernat
et al., 1993). This led us to isolate the responsible kinase secondary structure and is followed by the catalytic
domain, which contains the two activating phosphoryla-from brain, now termed MARK (Drewes et al., 1995).
Related MAPs such as MAP2 or MAP4 contain similar tion sites. The adjacent UBA domain argues for a regula-
tion of the enzymes by ubiquitin, possibly by tagging itrepeats; they are phosphorylated by MARKat analogous
Cell
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Figure 6. MARK Expression Leads to Hyperphosphorylation of Tau on KXGS Sites
Tau was transiently transfected into CHO cells that stably express MARK2 under control of a doxycyclin-inducible promoter. Cells were fixed
with formaldehyde and stained with anti-tau plus anti-tubulin (left panels) and a phospho-tau antibody specific for KXGS-type phosphorylation,
12E8 (right panels). Upper panels show cells in which MARK2 expression is induced, lower panels show the control without induction. The
left panels show double staining with tau and tubulin antibodies. Note that, after induction of MARK, the cells that do not express tau
(arrowheads) show a weakened microtubule array, compared to the control where no MARK expression had been induced (lower left panel).
The bright cells express tau (they are double labeled with tau and tubulin). The microtubule network of the tau-expressing cells remains more
intact, presumably because the overexpression of MAPs stabilizes microtubules. The right panels show the phosphorylation of KXGS motifs
on tau, as detected by the phosphorylation-dependent antibody 12E8. Phosphorylation of tau at KXGS motifs is observed when MARK
expression is induced (upper right panel) but not in the control without doxycyclin induction (lower right panel).
for degradation or membrane recruitment, as reported function and, hence, point out directions for future inves-
tigations. The protein bearing the highest homology, thefor the protooncogene c±cbl (Wang et al., 1996b). We
have indeed observed considerable proteolysis of human p78, was discovered as a marker that localizes
to the apical membrane of epithelial cells but is lostMARK in extracts from tissue or cells. The spacer region
differs from the rest of the protein in its hydrophilic upon carcinogenesis (Parsa, 1988). KIN1 and KIN2 (S.
cerevisiae) (Levin et al., 1987) show similarity to MARKand basic character, and little secondary structure is
predicted. Its basicity could point to membrane localiza- in their domain organization. Like p78, they localize to
the plasma membrane, and their function is unknowntion, in agreement with the fact that the kinase activity
could only be separated from the particulate fraction (Tibbetts et al., 1994). The related kin11 from S. pombe
is required for growth polarity; defective cells grow asby detergent extraction. The spacer domain is most
divergent between MARK1 and MARK2 (z50% homol- spheres (Levin and Bishop, 1990). par-1, which shows
a still higher homology with MARK, is involved in theogy), possibly accounting for the distinct localization in
transfected cells (Figure 4). In the C-terminal tail, homol- establishment of polarity in the early C. elegans embryo
(Guo and Kemphues, 1995).ogy between MARK1 and MARK2 is again high (90%),
and two short amphipathic helices are predicted. This Taken together with the biochemical data, the involve-
ment of MARK-related kinases in the establishment orpoints to an identical function of this domain in both
enzymes, possibly the interaction with other proteins by maintenance of polarity tempts us to hypothesize that
MARK might regulate MT dynamics during these events.coupling to their amphipathic helices (Segrest et al.,
1990). It has been reported that the PAR-1 tail domain MTs are key players in the generation of polarity, for
instance, in the rotational alignment of the centrosome±interacts with myosin II (Guo and Kemphues, 1996). The
overall hydrophilic and charges character of the protein nucleus complex in C. elegans and the orientation of
the spindle pole body in S. pombe (Chang and Nurse,might account for the high apparent Mr of 110, compared
to its predicted mass of 88 kDa. 1996; Whiteand Strome, 1996),or in neuronal differentia-
tion (Caceres and Kosik, 1990; Dinsmore and Solomon,The sequence relationship of MARK with kinases from
several other organisms might provide a clue to cellular 1991).
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MT-binding proteins containing sequences related to the catalytic domains of both kinases are very similar
and, in the case of tau protein, have identical substratethe tau repeats have been found in C. elegans (ptl-1;
McDermott et al., 1996). The high degree of conservation specificities in vitro. If MARK expression is induced in
cells transfected with tau, the cells stain with antibodyfound only in the repeats argues for a central role of
this motif in the function of these proteins. The KVGS 12E8, which detects phosphorylated KXGS motifs in
MAPs. The deleterious effects of MARK overexpressionmotifs in PTL-1 could be targets for phosphorylation by
PAR-1. The PAR-1 kinase shows a polar distribution could be blocked by the presence of the MT-stabilizing
drug taxotere, suggesting that the changes in morphol-preceding the asymmetric divisions of the early germ
cell lineage. This localization is not dependent on its ogy resulting from MARK expression are indeed medi-
ated by MT destabilization. Coexpression of tau and,activity, but on other par genes and on myosin II. Mu-
tants that are defective in kinase activity perform sym- more pronounced, MAP2c also counteracted the pheno-
type induced by MARK. This protective effect was en-metric first divisions, finally resulting in an amorphous
mass of differentiated cells (Guo and Kemphues, 1995, hanced if a mutant MAP2c was coexpressed in which
the main MARK target sites had been eliminated and1996). Failure of PAR-1 to trigger MT dynamics might
interfere with the correct placement of the mitotic spin- which thus binds to MTs irrespective of phosphoryla-
tion. These data strengthen the hypothesis that MT de-dle, which is a determinant of asymmetric division.
MARK1 and MARK2 show a wide tissue distribution, stabilization is mediated by MARK phosphorylation of
MAPs.expression being more pronounced in fetal than adult
samples. A 100 kDa kinase activity with biochemical The transfection experiments raise a few questions
about the current view of howthe MT cytoskeleton mightcharacteristics reminiscent of MARK copurifies with
MAP2 from chick embryos (Lopez and Sheetz, 1995). It be regulated. MAPs appear to be essential for certain
aspects of the cell cycle or differentiation involving MTsphosphorylated MAP2 and caused the loss of its MT
affinity. This activity was not associated with MAP2 puri- (e.g., tau and MAP2 in neuronal differentiation [Caceres
and Kosik, 1990; Dinsmore and Solomon, 1991]; MAP4fied from adult animals. Since fetal tissues contain
higher amounts of proliferating and differentiating cells, in myogenesis [Mangan and Olmsted, 1996]).Other work
suggests that removal of MAPs has no major conse-a more dynamic regulation of the MT cytoskeleton might
be expected, consistent with the observation that fetal quence. For example, removal of MAP4 from MTs in
fibroblasts resulted in no obvious effects (Wang et al.,MAPs are in a higher phosphorylation state (Watanabe
et al., 1993). 1996a), and mice lacking a functional tau gene did not
show a severe phenotype (Harada et al., 1994). TheseOne would expect a protein kinase with such potent
regulatory function to be strictly regulated itself. We results, however, might be explained by a functional
redundancy between the MAPs; i.e., cellular effectsshowed that active MARK is a phosphoprotein and that
kinase activity was lost after treatment with the Ser/Thr- might become visible only when several MAPs are im-
paired simultaneously. Cases of this kind are docu-specific phosphatase 2A. Peptide sequencing data gave
us a clue to the activation mechanism. Subdomain VIII mented for actin-binding proteins in Dictyostelium dis-
coideum (Witke et al., 1992). The observed disruptionof MARK contains phosphorylated Thr-215 and Ser-219,
which is analogous to the regulatory loops found in of the MT cytoskeleton could be a consequence of the
reduced stability of the MTs lacking MAPs. Such MAP-several kinase families, where single or dual phosphory-
lation is essential for enzyme activity (Johnson et al., deficient MTs could be prone to disruption, for example,
by catastrophe factors (Belmont and Mitchison, 1996;1996). Translation in vitro of MARK point mutants con-
firmedthat Thr-215 and Ser-219are essential for activity. Walczak et al., 1996).
In summary, MARKs phosphorylate MAPs and haveIn the MEKs, ERKs, and CDKs, the phosphorylation is
achieved by kinases acting upstream in the respective the potential to disrupt the MT network. Active MARKs
are phosphorylated, probably by upstream factors. Thissignaling cascades. Likewise, MARK activity could not
be fully restored by autophosphorylation, but we have could provide a mechanism by which extracellular sig-
nals control the stability of the cytoskeleton. MARK-been able to reactivate dephosphorylated MARK by the
addition of crude fractions from brain tissue, which sug- related proteins in other organisms are involved in the
development of cell polarity. In Alzheimer's disease, thegests the existence of a distinct activating factor (un-
published data). The phospho-Ser residue is part of a neuronal polarity is lost, and axonal tau protein accumu-
Ser±Pro motif and hence might be a target of upstream lates in the somatodendritic compartment. Hence, one
proline-directed kinases. Brain MARK contains phos- might speculate that a defect in MARK function could
photyrosine, but here the dephosphorylation has no se- be a common link.
vere effect on the enzymatic activity. However, other
functions, e.g. in protein±protein interactions, are not Experimental Procedures
excluded.
Overexpression of both MARK isoforms in CHO cells Purification of MARK
Porcine brains (2 kg) were homogenized in 2 l of buffer A (100 mMrevealed dramatic effects. Cells grew smaller and
Tris±HCl [pH 8.6], 2 mM EDTA, 100 mM NaF, 1 mM PMSF, 2 mMrounded, their MT array became disorganized or disap-
benzamidine, 1 mM Na3VO4, 1 mM DTT, 0.06% Brij-35), centrifugedpeared, and cells eventually died. The effect is depen-
at 100,000 3 g for 1 hr, and the extract was loaded onto a Whatman
dent on the enzymatic activity of the kinases; expression P11 column (10 3 5 cm) in buffer B (50 mM MES [pH 6.8], 2 mM
of inactive mutants had no effect. The effect of MARK2 EGTA, 50 mM NaF, 1 mM PMSF, 1 mM benzamidine, 1 mM Na3VO4,
was more pronounced than that of MARK1. This is prob- 1 mM DTT, 0.03% Brij-35). The column was washed with 1 l of buffer
B plus 150 mM NaCl and eluted with a 750 ml gradient (0.15±1 Mably due todifferences in regulationor localization, since
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NaCl) at 15 ml/min. Fractions were assayed by phosphorylation of restriction sites. For doxycyclin-inducible expression, we con-
structed plasmid pIndMARKII by inserting the coding region ofa synthetic peptide, TR1 (NVKSKIGSTENLK). Pools were dialyzed
against buffer A, loaded onto Q-Sepharose (Pharmacia; 80 3 16 pBlK2 into pUHD10±3 (Gossen et al., 1995). pUHD172±1neo was a
gift of Dr. H. Bujard, ZMBH Heidelberg (Gossen et al., 1995). Allmm), and eluted with a gradient from 0±0.5 M NaCl (flow rate 5 5
ml/min, 7 ml fractions). The active pool (40 ml) was desalted on MARK plasmids were 59-tagged by insertion of a sequence derived
from influenza haemagglutinin (HA), CATATGGGATCCTACCCTTACSephadex G25 and loaded onto a Mono S HR10/10 column (Phar-
macia; flow rate 5 4 ml/min, 7 ml fractions). Active fractions (40 ml) GACGTCCCTGACTACGCGTCCGATA. Site-directed mutagenesis
was performed using the QuickChange kit (Stratagene). Humanwere concentrated on a Mono Q HR 5/5 column and gel filtered
(Pharmacia Superdex 200; 300 3 16 mm) in buffer A (adjusted to cDNAs for tau40 and MAP2c were gifts of Drs. M. Goedert (MRC
Cambridge, UK) and C. Garner (University of Alabama, Birmingham,pH 7.8 plus 150 mM NaCl, flow rate 5 0.1 ml/min, 2 ml fractions).
After gel filtration in buffer C (40 mM b-glycerophosphate containing AL), respectively, and were inserted into pEUHATag.
10 mM MgCl2, 2 mM EGTA, 1 mM benzamidine, 0.2 mM DTT), active
pools were loaded at 0.05 ml/min onto a 1 ml column of g-phos- Antibodies
phate-linked ATP±Sepharose (UBI). The enzyme was eluted with 5 The following antibodies were used: Mouse monoclonals anti-HA
mM MgATP, dialyzed against buffer A containing 50% (v/v) glycerol, (12CA5; Boehringer), anti-TauS262P (12E8; a gift from Dr. D. Schenk,
and stored at 2208C. Twenty micrograms of purified MARK was Athena Neuroscience), anti-P-Tyr (4G10; UBI), and anti-tubulin (DM1A;
incubated with 6 M urea and 2 mM DTT for 2 hr at 308C and reacted Sigma); rat anti-tubulin (YL1/2; Sera-lab); and rabbit polyclonal anti-
with 5 mM 4-vinylpyridine for 4 hr. After addition of 10 mM DTT, the tau (Dako). Secondary antibodies were fluorescein-conjugated goat
sample was gel filtered into 20 mM NH4HCO3 and digested with 2 anti-mouse and rhodamine-conjugated goat anti-rat and anti-rab-
mg of endoprotease Lys-C (Promega). Peptides were separated on bit (Dianova). Rabbit antisera were raised against MARK N- and
a Vydac 218TP52 column with a 16 ml gradient of 0%±60% acetoni- C-terminal peptides MSSARTPLPTLNERD and KNIASKIANELKL.
trile in 10 mM ammoniumacetate at 100 ml/min, further purified on
a Pharmacia mRPCC2/C18 column using a 10 ml gradient of 10% In Vitro Translation
(v/v) acetonitrile in 0.075% TFA to 66% acetonitril in 0.05% TFA at 80 Linearized plasmids were transcribed by T7 RNA polymerase and
ml/min, and sequenced on a 476A sequencer (ABI). Phosphoserines translated in reticulocyte lysate (Promega). Products were analyzed
and -threonines were identified as DTT adducts of PTH-dehydro- by blotting with MARK C-terminal antiserum. One-hundred-microli-
alanine or a-aminodehydrobutyric acid (Meyer et al., 1993). ter samples were gel filtered on a Pharmacia Superose 12±2.1/30
column in 40 mM HEPES (pH 7.2), 5 mM MgCl2, 2 mM EGTA; 0.1
mM DTT, 0.2 mM PMSF, 0.03% Brij-35, and the fraction eluting atcDNA Cloning
the position of phosphorylase B (97 kDa, used for calibration) wasThe sequences obtained from fractions 87 and 33 were used for
subjected to immunoprecipitation with anti-HA antibody preboundthe design of degenerate primers GA[CT]ACNTT[CT]TG[CT]GGN
to protein A/G-agarose (Dianova). Peptide TR1 (50 mM) or htau40[AT][CG]NCC and [CT]TC[AG]TC[AG]TC[CT]TC[AG]TGNCCNAC[AG]
(3 mM) and [g-32P]ATP (10 mM, 500 Ci/mmol, New England Nuclear)TTCATCCA, which were used in an RT±PCR with 0.1 mg rat brain
were incubated with the immunoprecipitates for 30 min at 378C.or human brain mRNA (Clontech). cDNA synthesis by AMV reverse
Phosphopeptide quantitation and mapping was performed as de-transcriptase (primed with oligo[dT] at 428C for 1 hr) was followed by
scribed (Drewes et al., 1995).amplification by Pyrococcus furiosus DNA-polymerase (Stratagene)
(30 cycles of 948C, 1 s, 598C, 30 s, and 718C, 60 s). The products
Dephosphorylation Assaywere reamplified in a nested PCR with GCNCCNGA[AG][CT]TNTT
Purified brain MARK (1 mU, transfers 1 nmol Pi/min to MAP2c at[CT]CA[AG]GG designed from the C-terminal portion of peptide 87.
378C) was incubated with 0.5 mg PP2A or PTP1B (a gift of Dr. N.The amplified fragment was cloned and sequenced.Labeled probes
Tonks, Cold Spring Harbor Laboratory, NY) in 50 mM Tris±HCl (pHwere generated by PCR using [a-32P]dATP and used to screen 106
7.4), 0.1 mM DTT, 0.1 mM PMSF, 5% (v/v) glycerol, final volumeclones of a rat brain cDNA library in lZAPII (Stratagene). Filters were
50 ml, at 378C. The reactions were terminated by the addition ofhybridized in 53 SSPE (0.4 M NaH2PO4 [pH 7.4], 0.75 M NaCl, 5 mM
microcystin-LR (1 mM, Biomol) or Na3VO4 (1 mM).EDTA), 100 mg/ml salmon sperm DNA, 53 Denhardt's, 1% (w/v)
SDS, and 50% (v/v) formamide at 428C for 16 hr and washed in
Cell Culture0.23 SSPE, 0.1% SDS at 608C for 3 3 30 min. Six positive plaques
CHO cells were grown in HAM's F12 medium/10% FCS/5% CO2 at(pBlK1±pBlK6) were identified by autoradiography and further puri-
378C, seeded at 70% confluency in 24-well plates on coverslips,fied by the same procedure. From these, pBluescript plasmids were
and transfected with 1 mg of DNA using 2 ml lipofectamine (GIBCO)rescued and sequenced on both strands. For the missing 59-end of
or DOTAP (Boehringer Mannheim). Stable transfectants ofclone pBlK1, the screening was repeated using a 350 bp probe
pUHD172±1neo were selected in the presence of 800 mg/ml genet-generated by PCR from the 59-end of the incomplete clone. An
icin (CHO172±1). For inducible expression, pIndMARK2 was co-overlapping clone (pBlK7) was isolated and fused to pBlK1, yielding
transfected with pBabePuro into CHO172±1 cells, and stablepBlK17.
transfectants recloned in the presence of 2 mg/ml puromycin. Ex-
pression was induced with 1 mg/ml doxycyclin for 1±2 days. Immu-
Northern Blotting nofluorescence analysis was performed 8±24 hr after transfection.
Northern blots were performed using 2 mg of poly(A)1 RNA isolated Cells were washed in 80 mM Pipes, 1mM MgCl2, 1 mM EGTA, 4%
from different tissues, fractionated by denaturing agarose gel elec- (w/v) polyethylene glycol (pH 6.9), fixed with methanol at 2208C for
trophoresis, and transferred to nylon membranes (Clontech). Equal 5 min or paraformaldehyde for 30 min at 378C, permeabilized with
loading was ensured by hybridization with an actin probe. cDNA 0.2% Triton X-100 in PBS, treated with 5% nonfat dry milk in PBS
probes for MARK were generated by random primer labeling or for 1 hr, and incubated with primary antibody for 1 hr at 378C and
PCR. Oligonucleotideprobes (45-mers) for MARK1 and MARK2 were with secondary antibody at 1:300 dilution for 30 min. All reagents
designed in divergent regions (amino acids 28±42 and 667±681 in were from Sigma, and taxotere was from Rhone-Poulenc Rorer (Vi-
MARK1 and amino acids 19±33 and 592±604 in MARK2). The probes try, France). Microscopy was performed with a Zeiss Axioplan using
(1±3 pmol) were labeled to 107 cpm/pmol by T4 polynucleotide ki- filters optimized for double-label experiments and a 633 objective.
nase and/or terminal transferase (Boehringer) and hybridized in 53
SSPE, 23 Denhardt's, 100 mg/ml salmon sperm DNA, and 0.5% Acknowledgments
SDS at 428C. Washes were conducted in 0.53 SSPE, 1% SDS.
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GenBank Accession Numbers
The GenBank accession numbers for the MARK1 and MARK2 se-
quences are Z83868 and Z83869, respectively.
